A multicenter prospective study showed that 29 of 295 (9.8%) EGFR-wild type patients with lung adenocarcinoma were positive for EML4-ALK translocation, which occurred more frequently in patients younger than 65 years [14,16]. Here, EGFR is linked to lung adenocarcinoma.